TLDR:
- Benjamin Kim PhD has been promoted to Partner at Playground Global.
- He focuses on revolutionizing engineered biology and drug development.
Playground Global, a deep-tech venture firm, announced the promotion of Benjamin Kim PhD to Partner. Ben’s focus is on identifying founders and companies that are revolutionizing engineered biology, building the future of emerging modality therapeutics development, and unlocking AI and ML workflows to refactor drug development. He joined Playground as a Venture Fellow in 2019, while completing his PhD in bioengineering at Stanford University. In the last year, Ben has played a crucial role in supporting investments in various biotech companies and has been promoted from Venture Fellow to Venture Principal. His promotion follows the addition of Nate Chang as a biotech Operating Partner and the firm’s recent close of $410 million in new capital, bringing its assets under management to more than $1.2 billion. Playground Global focuses on Seed and Series A companies across next-gen computing, logistics, automation, infrastructure, decarbonization and engineered biology, with initial investments ranging from $1 million to $20 million.
